These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9559995)

  • 21. Differential immune response to gangliosides in Guillain-Barré syndrome patients from Japan and The Netherlands.
    Ang CW; Koga M; Jacobs BC; Yuki N; van der Meché FG; van Doorn PA
    J Neuroimmunol; 2001 Dec; 121(1-2):83-7. PubMed ID: 11730944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
    Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
    Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the neurological diseases associated with Mycoplasma pneumoniae infection and anti-glycolipid antibodies.
    Kuwahara M; Samukawa M; Ikeda T; Morikawa M; Ueno R; Hamada Y; Kusunoki S
    J Neurol; 2017 Mar; 264(3):467-475. PubMed ID: 28025664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 3-year-old boy with Guillain-Barré syndrome and encephalitis associated with Mycoplasma pneumoniae infection.
    Hanzawa F; Fuchigami T; Ishii W; Nakajima S; Kawamura Y; Endo A; Arakawa C; Kohira R; Fujita Y; Takahashi S
    J Infect Chemother; 2014 Feb; 20(2):134-8. PubMed ID: 24462436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
    Shimoya K; Ohnishi A; Hashimoto T; Yuki N
    Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical features and response to treatment in Guillain-Barré syndrome associated with antibodies to GM1b ganglioside.
    Yuki N; Ang CW; Koga M; Jacobs BC; van Doorn PA; Hirata K; van der Meché FG
    Ann Neurol; 2000 Mar; 47(3):314-21. PubMed ID: 10716250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coexisting anti-I and anti-F1/Gd cold agglutinins in infections by Mycoplasma pneumoniae.
    König AL; Kreft H; Hengge U; Braun RW; Roelcke D
    Vox Sang; 1988; 55(3):176-80. PubMed ID: 2853491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-GM1 antibodies in patients with Guillain-Barré syndrome.
    van den Berg LH; Marrink J; de Jager AE; de Jong HJ; van Imhoff GW; Latov N; Sadiq SA
    J Neurol Neurosurg Psychiatry; 1992 Jan; 55(1):8-11. PubMed ID: 1548508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Simone IL; Annunziata P; Maimone D; Liguori M; Leante R; Livrea P
    J Neurol Sci; 1993 Jan; 114(1):49-55. PubMed ID: 8433097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GM1b is a new member of antigen for serum antibody in Guillain-Barré syndrome.
    Kusunoki S; Iwamori M; Chiba A; Hitoshi S; Arita M; Kanazawa I
    Neurology; 1996 Jul; 47(1):237-42. PubMed ID: 8710085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Search for antibodies to neutral glycolipids in sera of patients with Guillain-Barré syndrome.
    Ilyas AA; Mithen FA; Chen ZW; Cook SD
    J Neurol Sci; 1991 Mar; 102(1):67-75. PubMed ID: 1856733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barre syndrome.
    Ilyas AA; Chen ZW; Cook SD; Mithen FA; Singhal BS
    Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):115-23. PubMed ID: 11458979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.
    Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H
    J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Association of IgA anti-GM1 antibody with antecedent diarrhea in patients with Guillain-Barré syndrome].
    Koga M; Yuki N; Hirata K
    Rinsho Shinkeigaku; 1997 Sep; 37(9):848-50. PubMed ID: 9431003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies to GM1(NeuGc) in Guillain-Barré syndrome after ganglioside therapy.
    Odaka M; Yuki N; Nobile-Orazio E; Carpo M; Hirata K
    J Neurol Sci; 2000 Apr; 175(2):96-106. PubMed ID: 10831769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
    Yuki N
    Rinsho Shinkeigaku; 1999 Jan; 39(1):17-8. PubMed ID: 10377788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute oropharyngeal palsy associated with anti-GM1b IgG antibody.
    Ikuta N; Fukusako T; Yuki N; Morimatsu M; Koga M
    J Neurol; 2003 Jul; 250(7):881-2. PubMed ID: 12883937
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin.
    Fredman P; Vedeler CA; Nyland H; Aarli JA; Svennerholm L
    J Neurol; 1991 Apr; 238(2):75-9. PubMed ID: 1856740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IgM binding to sialosyllactosaminylparagloboside in a patient with polyradiculoneuropathy due to Mycoplasma pneumoniae infection.
    Inuzuka T; Miyatani N; Baba H; Tanaka M; Tanaka K; Sato S; Nakamura K; Miyatake T
    Acta Neurol Scand; 1988 Jul; 78(1):53-7. PubMed ID: 3140569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intrathecal antibody responses to GalC in Guillain-Barré syndrome triggered by Mycoplasma pneumoniae.
    Meyer Sauteur PM; Huizinga R; Tio-Gillen AP; Drenthen J; Unger WWJ; Jacobs E; van Rossum AMC; Jacobs BC
    J Neuroimmunol; 2018 Jan; 314():13-16. PubMed ID: 29301655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.